Companies Dominating the Cancer Vaccines Landscape
- AstraZeneca
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc.
- Sanofi
- Merck & Co Inc,
- Astellas Pharma Inc.
- VBI Vaccines Inc.
- Moderna, Inc.
- Advaxis Immunotherapies
- Galena Biopharma
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of cancer vaccines is evaluated at USD 11.48 billion.
Cancer Vaccines Market size was valued at USD 10.45 billion in 2024 and is set to exceed USD 43.53 billion by 2037, expanding at over 11.6% CAGR during the forecast period i.e., between 2025-2037.
North America industry is estimated to dominate majority revenue share by 2037, as a result of highly developed healthcare infrastructure as well as presence of leading key players in the region.
The major players in the market are AstraZeneca, Bristol-Myers Squibb Company, GlaxoSmithKline plc., Sanofi, Merck & Co Inc, Astellas Pharma Inc., VBI Vaccines Inc., Moderna, Inc., Advaxis Immunotherapies and Galena Biopharma.
The major players in the market are AstraZeneca, Bristol-Myers Squibb Company, GlaxoSmithKline plc., Sanofi, Merck & Co Inc, Astellas Pharma Inc., VBI Vaccines Inc., Moderna, Inc., Advaxis Immunotherapies and Galena Biopharma.
